Cd19tm1(cre)Cgn/Cd19+ Rbpjtm1Hon/Rbpjtm1Hon
involves: 129P2/OlaHsd * C57BL/6
|
abnormal B cell differentiation |
J:76240
|
decreased marginal zone B cell number |
J:76240,
J:121523
|
increased follicular B cell number |
J:76240,
J:121523
|
increased IgG3 level |
J:76240
|
increased susceptibility to bacterial infection |
J:76240
|
increased susceptibility to bacterial infection induced morbidity/mortality |
J:76240
|
Pax3tm1(cre)Joe/Pax3+ Rbpjtm1Hon/Rbpjtm1Hon
involves: 129P2/OlaHsd
|
abnormal diaphragm morphology |
J:120053
|
abnormal dorsal interneuron 4 morphology |
J:130251
|
abnormal epaxial muscle morphology |
J:120053
|
abnormal glutaminergic neuron morphology |
J:130251
|
abnormal intercostal muscle morphology |
J:120053
|
abnormal myogenesis |
J:120053
|
abnormal neural tube morphology |
J:130251
|
abnormal neuron differentiation |
J:130251
|
decreased neuronal precursor cell number |
J:130251
|
decreased satellite cell number |
J:120053
|
hypaxial muscle hypoplasia |
J:120053
|
loss of GABAergic neurons |
J:130251
|
neonatal lethality, complete penetrance |
J:120053
|
no spontaneous movement |
J:120053
|
respiratory failure |
J:120053
|
Pgrtm2(cre)Lyd/Pgr+ Rbpjtm1Hon/Rbpjtm1Hon
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
|
abnormal decidualization |
J:326956
|
Ptf1atm1(cre)Hnak/Ptf1a+ Rbpjtm1Rsch/Rbpjtm1Rsch
involves: 129X1/SvJ
|
abnormal digestion |
J:139250
|
abnormal pancreas development |
J:139250
|
abnormal pancreas morphology |
J:139250
|
abnormal pancreatic alpha cell differentiation |
J:139250
|
decreased pancreatic acinar cell number |
J:139250
|
decreased pancreatic islet number |
J:139250
|
disorganized pancreatic islets |
J:139250
|
increased pancreatic alpha cell number |
J:139250
|
postnatal growth retardation |
J:139250
|
postnatal lethality, complete penetrance |
J:139250
|
small pancreas |
J:139250
|
Rbpjtm1.1Hon/Rbpj+
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
|
abnormal retina vasculature morphology |
J:254752
|
Rbpjtm1.1Rsch/Rbpjtm1.1Rsch
involves: 129X1/SvJ
|
prenatal lethality, complete penetrance |
J:139250
|
Rbpjtm1b(EUCOMM)Hmgu/Rbpj+
C57BL/6N-Rbpjtm1b(EUCOMM)Hmgu/J
|
decreased bone mineral density |
J:211773
|
decreased circulating HDL cholesterol level |
J:211773
|
improved glucose tolerance |
J:211773
|
increased circulating bilirubin level |
J:211773
|
increased grip strength |
J:211773
|
Rbpjtm1b(EUCOMM)Hmgu/Rbpjtm1b(EUCOMM)Hmgu
C57BL/6N-Rbpjtm1b(EUCOMM)Hmgu/J
|
embryonic lethality prior to tooth bud stage |
J:211773
|
preweaning lethality, complete penetrance |
J:211773
|
Rbpjtm1Hon/Rbpj+ Tg(Tyr-cre)2Lru/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
|
normal
pigmentation phenotype |
J:116658
|
Rbpjtm1Hon/Rbpjtm1.1Hon Shhtm2(cre/ERT2)Cjt/Shh+
involves: 129P2/OlaHsd * 129S6/SvEvTac
|
abnormal respiratory epithelium morphology |
J:150051
|
absent club cells |
J:150051
|
Rbpjtm1Hon/Rbpjtm1.1Hon Tg(Pax7-cre/ERT2)1Cbm/0
involves: 129P2/OlaHsd * BALB/cJ
|
abnormal glutaminergic neuron morphology |
J:130251
|
abnormal neural tube morphology |
J:130251
|
abnormal neuron differentiation |
J:130251
|
decreased neuronal precursor cell number |
J:130251
|
loss of GABAergic neurons |
J:130251
|
Rbpjtm1Hon/Rbpjtm1Hon
involves: 129P2/OlaHsd * C57BL/6
|
normal
immune system phenotype |
J:76240
|
Rbpjtm1Hon/Rbpjtm1Hon Commd10Tg(Vav1-icre)A2Kio/Commd10+
involves: 129P2/OlaHsd * C57BL/10 * CBA/Ca
|
decreased tumor growth/size |
J:162770
|
Rbpjtm1Hon/Rbpjtm1Hon Mesp1tm2(cre)Ysa/Mesp1+
involves: 129P2/OlaHsd * C57BL/6 * CBA
|
abnormal atrioventricular cushion morphology |
J:139209
|
abnormal cardiac epithelial to mesenchymal transition |
J:139209
|
abnormal heart development |
J:139209
|
Rbpjtm1Hon/Rbpjtm1Hon Tg(Cd4-cre)1Cwi/?
involves: 129P2/OlaHsd * C57BL/6 * DBA
|
abnormal T-helper 2 cell differentiation |
J:90018
|
Rbpjtm1Hon/Rbpjtm1Hon Tg(Col1a1-cre)1Kry/0
involves: 129P2/OlaHsd * C57BL/6 * FVB/N
|
normal
skeleton phenotype |
J:233131
|
Rbpjtm1Hon/Rbpjtm1Hon Tg(Cyp1a1-cre)1Dwi/0
involves: 129P2/OlaHsd * C57BL/6 * CBA
|
abnormal crypts of Lieberkuhn morphology |
J:99348
|
abnormal intestinal epithelium morphology |
J:99348
|
abnormal intestinal goblet cell morphology |
J:99348
|
Rbpjtm1Hon/Rbpjtm1Hon Tg(Itgax-cre)1-1Reiz/0
involves: 129P2/OlaHsd * C57BL/6 * CBA
|
abnormal cytokine secretion |
J:125869
|
decreased dendritic cell number |
J:125869
|
Rbpjtm1Hon/Rbpjtm1Hon Tg(Lbx1-cre)3Cbm/0
involves: 129P2/OlaHsd
|
abnormal myogenesis |
J:120053
|
abnormal suckling behavior |
J:120053
|
decreased satellite cell number |
J:120053
|
decreased skeletal muscle fiber density |
J:120053
|
hypaxial muscle hypoplasia |
J:120053
|
neonatal lethality, complete penetrance |
J:120053
|
Rbpjtm1Hon/Rbpjtm1Hon Tg(Lck-cre)19Hhan/0
involves: 129P2/OlaHsd * C57BL/6 * DBA
|
abnormal CD4-positive helper T cell morphology |
J:168475
|
abnormal immune system physiology |
J:168475
|
abnormal regulatory T cell physiology |
J:168475
|
normal
immune system phenotype |
J:168475
|
increased macrophage cell number |
J:168475
|
increased single-positive T cell number |
J:168475
|
increased splenocyte number |
J:168475
|
increased T cell number |
J:168475
|
increased T cell proliferation |
J:168475
|
Rbpjtm1Hon/Rbpjtm1Hon Tg(MMTV-cre)1Mam/0
involves: 129P2/OlaHsd * C57BL/6J * FVB * SJL
|
abnormal mammary gland growth during pregnancy |
J:108712
|
epidermal cyst |
J:108712
|
hyperkeratosis |
J:108712
|
Rbpjtm1Hon/Rbpjtm1Hon Tg(Mx1-cre)1Cgn/0
involves: 129P2/OlaHsd * C57BL/6 * CBA
|
abnormal B cell differentiation |
J:99747
|
abnormal lymphopoiesis |
J:99747
|
arrested T cell differentiation |
J:99747,
J:125869
|
decreased dendritic cell number |
J:125869
|
decreased double-positive T cell number |
J:99747
|
decreased follicular dendritic cell number |
J:125869
|
decreased marginal zone B cell number |
J:76240,
J:99747
|
decreased single-positive T cell number |
J:99747
|
decreased thymocyte number |
J:99747
|
increased B cell number |
J:99747,
J:125869
|
increased double-negative T cell number |
J:99747
|
increased follicular B cell number |
J:99747
|
increased macrophage cell number |
J:125869
|
increased monocyte cell number |
J:125869
|
increased plasmacytoid dendritic cell number |
J:125869
|
small thymus |
J:99747
|
Rbpjtm1Hon/Rbpjtm1Hon Tg(Nes-cre)1Wme/0
involves: 129P2/OlaHsd * C57BL/6 * CBA
|
abnormal cell differentiation |
J:82337
|
epidermal cyst |
J:82337
|
hyperkeratosis |
J:82337
|
loss of vibrissae |
J:82337
|
premature hair loss |
J:82337
|
thick epidermis |
J:82337
|
Rbpjtm1Hon/Rbpjtm1Hon Tg(Pax2-cre)1Akg/0
involves: 129P2/OlaHsd
|
abnormal proximal convoluted tubule morphology |
J:119907
|
absent podocytes |
J:119907
|
embryonic lethality during organogenesis, complete penetrance |
J:119907
|
Rbpjtm1Hon/Rbpjtm1Hon Tg(Tek-cre)1Ywa/0
involves: 129S7/SvEvBrd * C57BL/6 * SJL
|
embryonic lethality, incomplete penetrance |
J:158959
|
Rbpjtm1Hon/Rbpjtm1Hon Tg(Tyr-cre)2Lru/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
|
diluted coat color |
J:116658
|
normal
pigmentation phenotype |
J:116658
|
Rbpjtm1Hon/Rbpjtm1Hon Tg(Tyr-cre)#Lru/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
|
abnormal hair follicle melanocyte morphology |
J:111228
|
abnormal hair follicle melanogenesis |
J:111228
|
abnormal melanoblast morphology |
J:111228
|
absent coat pigmentation |
J:111228
|
decreased melanocyte number |
J:111228
|
diluted coat color |
J:111228
|
Rbpjtm1Hon/Rbpjtm1Hon Tg(Vil1-cre/ERT2)23Syr/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
|
abnormal crypts of Lieberkuhn morphology |
J:99348
|
Rbpjtm1Kyo/Rbpj+
involves: 129S2/SvPas * CD-1
|
abnormal aortic valve morphology |
J:187551
|
abnormal heart echocardiography feature |
J:187551
|
aortic valve inflammation |
J:187551
|
calcified aortic valve cusp |
J:187551
|
cardiac fibrosis |
J:187551
|
decreased cardiac muscle contractility |
J:187551
|
thick aortic valve cusps |
J:187551
|
Rbpjtm1Kyo/Rbpjtm1Hon Tg(Tek-cre)12Flv/0
involves: 129P2/OlaHsd * C3H * C57BL/6
|
abnormal anterior cardinal vein morphology |
J:93125
|
abnormal common cardinal vein morphology |
J:93125
|
abnormal dorsal aorta morphology |
J:93125
|
abnormal vascular regression |
J:93125
|
absent vitelline blood vessels |
J:93125
|
arteriovenous malformation |
J:93125
|
embryonic growth retardation |
J:93125
|
pericardial effusion |
J:93125
|
Rbpjtm1Kyo/Rbpjtm1Kyo
involves: 129S2/SvPas
|
abnormal fetal cardiomyocyte proliferation |
J:119151
|
abnormal humoral immune response |
J:123631
|
abnormal myocardium layer morphology |
J:119151
|
abnormal response to infection |
J:123631
|
decreased interleukin-4 secretion |
J:123631
|
disorganized myocardium |
J:119151
|
trabecula carnea hypoplasia |
J:119151
|
Rbpjtm1Kyo/Rbpjtm1Kyo
involves: 129S2/SvPas * C57BL/6
|
abnormal anterior cardinal vein morphology |
J:93125
|
abnormal blood vessel morphology |
J:93125
|
abnormal common cardinal vein morphology |
J:93125
|
abnormal dorsal aorta morphology |
J:93125
|
abnormal placental labyrinth vasculature morphology |
J:93125
|
abnormal vascular regression |
J:93125
|
abnormal vitelline vascular remodeling |
J:93125
|
arteriovenous malformation |
J:93125
|
decreased spongiotrophoblast size |
J:93125
|
embryonic growth retardation |
J:93125
|
embryonic lethality between somite formation and embryo turning, complete penetrance |
J:57072
|